[1]
A. B. Bahçecioğlu and Y. Büyükaşık, “Single-center real-world data on the efficacy, safety, and current availability of pegylated interferon-α in hematologic neoplasms”, Acta Medica, vol. 57, no. 1, pp. 58–66, Mar. 2026.